Inhibition of 2′,5′-oligoadenylate synthetase expression and function by the human cytomegalovirus ORF94 gene product

Journal of Virology

Volumn 85, Issue 11, 2011, Pages 5696-5700

  Tan, Joanne C G ^a   Avdic, Selmir ^a   Cao, John Z ^a   Mocarski, Edward S ^b   White, Kirsten L ^c   Abendroth, Allison ^a   Slobedman, Barry ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b EMORY UNIVERSITY   (United States)

^c GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; GENE PRODUCT; ORF94; UNCLASSIFIED DRUG; VIRULENCE FACTOR; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST CULTURE; GENETIC TRANSFECTION; HELA CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; INHIBITION KINETICS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS CELL INTERACTION; CELL CULTURE; CYTOMEGALOVIRUS; DRUG ANTAGONISM; FIBROBLAST; HOST PATHOGEN INTERACTION; METABOLISM; PATHOGENICITY; VIROLOGY;

HUMAN HERPESVIRUS 5;

2',5'-OLIGOADENYLATE SYNTHETASE; CELLS, CULTURED; CYTOMEGALOVIRUS; FIBROBLASTS; HOST-PATHOGEN INTERACTIONS; HUMANS; VIRAL PROTEINS; VIRULENCE FACTORS;

EID: 79956065291     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02463-10     Document Type: Article

References (31)

1. Abate, D. A., S. Watanabe, and E. S. Mocarski. 2004. Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J. Virol. 78:10995-11006.
2. Baglioni, C., M. A. Minks, and P. A. Maroney. 1978. Interferon action may be mediated by activation of a nuclease by pppA2′p5′A2′p5′A. Nature 273:684-687.
3. Bego, M., J. Maciejewski, S. Khaiboullina, G. Pari, and S. St. Jeor. 2005. Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J. Virol. 79:11022-11034.
4. Boyle, K. A., R. L. Pietropaolo, and T. Compton. 1999. Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Mol. Cell. Biol. 19:3607-3613.
5. Browne, E. P., and T. Shenk. 2003. Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc. Natl. Acad. Sci. U. S. A. 100:11439-11444.
6. Cheung, A. K., et al. 2009. The role of the human cytomegalovirus UL111A gene in down-regulating CD4_ T-cell recognition of latently infected cells: implications for virus elimination during latency. Blood 114:4128-4137.
7. Child, S. J., M. Hakki, K. L. De Niro, and A. P. Geballe. 2004. Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. J. Virol. 78:197-205.
8. Clemens, M. J., and B. R. Williams. 1978. Inhibition of cell-free protein synthesis by pppA2′p5′A2′p5′A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell 13:565-572.
9. De Preter, K., et al. 2002. Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. Mod. Pathol. 15:159-166.
10. Hahn, G., R. Jores, and E. S. Mocarski. 1998. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. U. S. A. 95:3937-3942.
11. Hakki, M., and A. P. Geballe. 2005. Double-stranded RNA binding by human cytomegalovirus pTRS1. J. Virol. 79:7311-7318.
12. Jenkins, C., A. Abendroth, and B. Slobedman. 2004. A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J. Virol. 78:1440-1447.
13. Justesen, J., R. Hartmann, and N. O. Kjeldgaard. 2000. Gene structure and function of the 2′-5′-oligoadenylate synthetase family. Cell. Mol. Life Sci. 57:1593-1612.
14. Kondo, K., H. Kaneshima, and E. S. Mocarski. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. U. S. A. 91:11879-11883.
15. Kondo, K., J. Xu, and E. S. Mocarski. 1996. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc. Natl. Acad. Sci. U. S. A. 93:11137-11142.
16. Kristiansen, H., et al. 2010. Extracellular 2′-5′ oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity. J. Virol. 84:11898-11904.
17. Landini, M. P., T. Lazzarotto, J. Xu, A. P. Geballe, and E. S. Mocarski. 2000. Humoral immune response to proteins of human cytomegalovirus latencyassociated transcripts. Biol. Blood Marrow Transplant. 6:100-108.
18. Lunetta, J. M., and J. A. Wiedeman. 2000. Latency-associated sense transcripts are expressed during in vitro human cytomegalovirus productive infection. Virology 278:467-476.
19. Marshall, E. E., C. J. Bierle, W. Brune, and A. P. Geballe. 2009. Essential role for either TRS1 or IRS1 in human cytomegalovirus replication. J. Virol. 83:4112-4120.
20. Marshall, E. E., and A. P. Geballe. 2009. Multifaceted evasion of the interferon response by cytomegalovirus. J. Interferon Cytokine Res. 29:609-619.
21. Miller, D. M., Y. Zhang, B. M. Rahill, W. J. Waldman, and D. D. Sedmak. 1999. Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. J. Immunol. 162:6107-6113.
22. Mocarski, E. S., T. Shenk, and R. F. Pass. 2007. Cytomegaloviruses, p. 2701-2772. In D. M. Knipe et al. (ed.), Fields virology, 5th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, PA.
23. Powers, C., V. DeFilippis, D. Malouli, and K. Fruh. 2008. Cytomegalovirus immune evasion. Curr. Top. Microbiol. Immunol. 325:333-359.
24. Sanchez, R., and I. Mohr. 2007. Inhibition of cellular 2′-5′ oligoadenylate synthetase by the herpes simplex virus type 1 Us11 protein. J. Virol. 81:3455-3464.
25. Silverman, R. H. 2007. Viral encounters with 2′,5′-oligoadenylate synthetase and RNase L during the interferon antiviral response. J. Virol. 81:12720-12729.
26. Simmen, K. A., et al. 2001. Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc. Natl. Acad. Sci. U. S. A. 98:7140-7145.
27. Slobedman, B., et al. 2010. Human cytomegalovirus latent infection and associated viral gene expression. Future Microbiol. 5:883-900.
28. Slobedman, B., and E. S. Mocarski. 1999. Quantitative analysis of latent human cytomegalovirus. J. Virol. 73:4806-4812.
29. White, K. L., B. Slobedman, and E. S. Mocarski. 2000. Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection. J. Virol. 74:9333-9337.
30. Zhu, H., J. P. Cong, G. Mamtora, T. Gingeras, and T. Shenk. 1998. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc. Natl. Acad. Sci. U. S. A. 95:14470-14475.
31. Zhu, H., J. P. Cong, and T. Shenk. 1997. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. Proc. Natl. Acad. Sci. U. S. A. 94:13985-13990.